Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05365477 · ClinicalTrials.gov registry record · Phase 4
Empiric Versus Selective Prevention Strategies for Kidney Stone Disease
A Phase 4 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT05365477: Completed Phase 4 study, sponsored by Vanderbilt University Medical Center.
NCT05365477 is a Phase 4 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 56 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05365477, a Phase 4 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
The aims of this study are to 1) Conduct a randomized clinical trial of selective versus empiric diet plus pharmacologic therapy in high-risk stone formers and 2) Determine adverse effects from, and adherence to selective and empiric strategies.
Primary Outcome
Calculated calcium oxalate supersaturation in urine
Interventions
- BEHAVIORAL Empiric Therapy: Diet
- DRUG Empiric Therapy: Drug
- BEHAVIORAL Selective Therapy: Diet
- DRUG Selective Therapy: Drug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2022-08-04 |
| Est. Completion | 2026-03-31 |
| Phase | Phase 4 |
What the finished NCT05365477 record still lists
NCT05365477 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 4 interventions - of which Empiric Therapy: Diet is the first listed.
NCT05365477 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05365477 about?
NCT05365477 is a clinical study titled "Empiric Versus Selective Prevention Strategies for Kidney Stone Disease". The aims of this study are to 1) Conduct a randomized clinical trial of selective versus empiric diet plus pharmacologic therapy in high-risk stone formers and 2) Determine adverse effects from, and adherence to selective and empiric strategies.
What is the current status of trial NCT05365477?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2022-08-04. Estimated completion is 2026-03-31.
What interventions are being tested in trial NCT05365477?
The interventions under investigation include: Empiric Therapy: Diet (BEHAVIORAL), Empiric Therapy: Drug (DRUG), Selective Therapy: Diet (BEHAVIORAL), Selective Therapy: Drug (DRUG).
Who is sponsoring clinical trial NCT05365477?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05365477's enrollment target sits among peer trials
56 1213th of 2000 higher than 783 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI